TIGIT and small cell lung carcinoma: The detailed classification of T cells in SCLC also revealed the expression patterns of markers of dysfunction and exhaustion (e.g., PDCD1, CTLA4, HAVCR2, LAG3, TIGIT, and LAYN), which might serve as immunotherapy targets (Supplementary Fig. S2c).